Keywords: fda, backs, eli, lilly/takeda, actos, launch, next

FDA backs Eli Lilly/Takeda's Actos, launch next month

Article | 20 July 1999

Print This

Actos (pioglitazone), which was developed by Takeda Chemical Industriesand will be comarketed in the USA by Eli Lilly, has been ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in